Rianlon Corp (300596) - Total Liabilities

Latest as of March 2026: CN¥5.58 Billion CNY ≈ $816.95 Million USD

Based on the latest financial reports, Rianlon Corp (300596) has total liabilities worth CN¥5.58 Billion CNY (≈ $816.95 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Rianlon Corp - Total Liabilities Trend (2011–2025)

This chart illustrates how Rianlon Corp's total liabilities have evolved over time, based on quarterly financial data. See working capital to net assets of Rianlon Corp to evaluate short-term liquidity relative to the company's equity base.

Rianlon Corp Competitors by Total Liabilities

The table below lists competitors of Rianlon Corp ranked by their total liabilities.

Company Country Total Liabilities
BlackRock Capital Allocation Trust
NYSE:BCAT
USA $370.43 Million
Innuovo Technology Co Ltd Class A
SHE:000795
China CN¥1.50 Billion
Sanbo Hospital Management Group Ltd. A
SHE:301293
China CN¥1.06 Billion
S-1 Corp
KO:012750
Korea ₩668.35 Billion
CCL Products (India) Limited
NSE:CCL
India Rs19.82 Billion
Despegar.com Corp
NYSE:DESP
USA $999.20 Million
Jiangyin Hengrun Heavy
SHG:603985
China CN¥2.57 Billion
Wangfujing
SHG:600859
China CN¥19.44 Billion

Liability Composition Analysis (2011–2025)

This chart breaks down Rianlon Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see 300596 stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.43 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.13 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.52 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Rianlon Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Rianlon Corp (2011–2025)

The table below shows the annual total liabilities of Rianlon Corp from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 CN¥5.53 Billion
≈ $809.65 Million
+25.52%
2024-12-31 CN¥4.41 Billion
≈ $645.03 Million
+12.06%
2023-12-31 CN¥3.93 Billion
≈ $575.61 Million
+7.63%
2022-12-31 CN¥3.65 Billion
≈ $534.80 Million
+23.82%
2021-12-31 CN¥2.95 Billion
≈ $431.91 Million
+80.74%
2020-12-31 CN¥1.63 Billion
≈ $238.97 Million
+34.73%
2019-12-31 CN¥1.21 Billion
≈ $177.37 Million
+32.01%
2018-12-31 CN¥918.22 Million
≈ $134.36 Million
+61.23%
2017-12-31 CN¥569.52 Million
≈ $83.34 Million
+42.95%
2016-12-31 CN¥398.39 Million
≈ $58.30 Million
+72.14%
2015-12-31 CN¥231.43 Million
≈ $33.87 Million
+6.29%
2014-12-31 CN¥217.74 Million
≈ $31.86 Million
-0.51%
2013-12-31 CN¥218.86 Million
≈ $32.03 Million
+31.77%
2012-12-31 CN¥166.09 Million
≈ $24.30 Million
+33.30%
2011-12-31 CN¥124.60 Million
≈ $18.23 Million
--

About Rianlon Corp

SHE:300596 China Specialty Chemicals
Market Cap
$1.63 Billion
CN¥11.15 Billion CNY
Market Cap Rank
#7036 Global
#1592 in China
Share Price
CN¥48.55
Change (1 day)
+5.52%
52-Week Range
CN¥27.92 - CN¥54.19
All Time High
CN¥6766.92
About

Rianlon Corporation provides anti-aging additives and application technologies for polymer materials industry in China and internationally. The company's products include primary antioxidants, secondary antioxidants, UV absorbers, HALS, u-pack, polymerization inhibitors, intermediates, light stabilizers, compound customized products, lubricant additives, cosmetics, and life sciences. Its products… Read more